New Republic Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
8,371
-2,303
-22% -$536K 0.69% 31
2025
Q4
$2.21M Buy
10,674
+5,117
+92% +$1.01M 0.59% 33
2025
Q3
$1.03M Buy
5,557
+225
+4% +$38.5K 0.32% 41
2025
Q2
$814K Buy
5,332
+335
+7% +$51.5K 0.29% 48
2025
Q1
$829K Buy
4,997
+656
+15% +$103K 0.36% 46
2024
Q4
$628K Buy
4,341
+9
+0.2% +$1.4K 0.41% 52
2024
Q3
$702K Buy
4,332
+65
+2% +$10.4K 0.4% 53
2024
Q2
$624K Sell
4,267
-345
-7% -$51.3K 0.31% 63
2024
Q1
$730K Buy
4,612
+223
+5% +$35.5K 0.46% 49
2023
Q4
$688K Buy
4,389
+583
+15% +$89.4K 0.49% 44
2023
Q3
$593K Buy
3,806
+653
+21% +$108K 0.48% 44
2023
Q2
$522K Buy
3,153
+572
+22% +$92.3K 0.36% 58
2023
Q1
$400K Sell
2,581
-85
-3% -$13.7K 0.3% 66
2022
Q4
$471K Buy
+2,666
New +$460K 0.37% 52

Other funds holding JNJ

New Republic Capital's JNJ Position: Q1 2026 in Review

New Republic Capital reduced its Johnson & Johnson (JNJ) stake by 22% in Q1 2026, selling an estimated $536K and leaving 8,371 shares worth $2.05M. The position accounts for 0.69% of the portfolio, ranked #31.

New Republic Capital first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.21M in Q4 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • New Republic Capital held 8,371 shares of Johnson & Johnson worth $2.05M as of Q1 2026.
  • New Republic Capital sold 2,303 Johnson & Johnson shares in Q1 2026, an estimated $536K.
  • Johnson & Johnson made up 0.69% of New Republic Capital's portfolio in Q1 2026, its #31 holding.
  • New Republic Capital first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • New Republic Capital's Johnson & Johnson position peaked at $2.21M in Q4 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.